Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14858]

ESMO 2023: Dual-action drug produces positive results in patients with advanced neuroendocrine tumours, trial finds

ESMO 2023: Dual-action drug produces positive results in patients with advanced neuroendocrine tumours, trial finds

ESMO 2023: Advances in gynaecological cancer research could change the treatment landscape

ESMO 2023: Advances in gynaecological cancer research could change the treatment landscape

ESMO 2023: Lung cancer treatment research enters a new era

ESMO 2023: Lung cancer treatment research enters a new era

ESMO 2023: Cemiplimab neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma

ESMO 2023: Cemiplimab neoadjuvant treatment demonstrates encouraging event-free survival in patients with...

mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma

mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma

Can lifestyle interventions benefit patients with advanced breast cancer?

Can lifestyle interventions benefit patients with advanced breast cancer?

Genetic risk scores not useful in predicting disease

Genetic risk scores not useful in predicting disease

New cancer therapy target stops tumour cells from sharing resources

New cancer therapy target stops tumour cells from sharing resources

Novel CDK12/13 small molecule inhibitor a preclinical candidate for multiple tumours

Novel CDK12/13 small molecule inhibitor a preclinical candidate for multiple tumours

Unlocking secrets of immune system proteins: A potential path to new treatments

Unlocking secrets of immune system proteins: A potential path to new treatments

More from ecancer